| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 |
| filingDate |
2011-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101537148-B1 |
| titleOfInvention |
Purinone derivative |
| abstract |
The compounds represented by the following formula (I) (wherein all symbols are the same as those described in the specification) are compounds which are excellent in metabolic stability and can avoid hepatotoxicity, in addition to those having Btk selective inhibitory activity, B cells or mast cell-related diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160028509-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140095516-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101636631-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102021651-B1 |
| priorityDate |
2010-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |